2017
DOI: 10.1039/c7bm00286f
|View full text |Cite
|
Sign up to set email alerts
|

Fibroblast fate regulation by time dependent TGF-β1 and IL-10 stimulation in biomimetic 3D matrices

Abstract: The presentation of TGF-β1 during the early stage of wound healing is a prerequisite for extracellular matrix (ECM) synthesis and remodeling by activated fibroblasts, called myofibroblasts. At later stages, clearance of myofibroblasts is needed to avoid overshooting ECM production. Apoptosis of myofibroblasts and the macrophage-released anti-inflammatory cytokine IL-10 are controversially discussed as regulating cues in this context. To reveal the regulating cues, defined biomaterial scaffolds are needed to co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
54
0
4

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 58 publications
(70 citation statements)
references
References 54 publications
12
54
0
4
Order By: Relevance
“…In addition, our results suggest that M -IL-4/-IL-13 appears to have a characteristic of the M2a phenotype, similar to other reports that cultured their cells on 2D surfaces [27], since these cells secreted high amounts of TGF-β1 and in turn triggered fibroblast differentiation [67,86]. This hypothesis is also supported by a very low secreted amount of IL-10, which can dedifferentiate myofibroblast back into fibroblasts, as previously reported [69,76].…”
Section: General Discussion and Conclusionsupporting
confidence: 90%
See 1 more Smart Citation
“…In addition, our results suggest that M -IL-4/-IL-13 appears to have a characteristic of the M2a phenotype, similar to other reports that cultured their cells on 2D surfaces [27], since these cells secreted high amounts of TGF-β1 and in turn triggered fibroblast differentiation [67,86]. This hypothesis is also supported by a very low secreted amount of IL-10, which can dedifferentiate myofibroblast back into fibroblasts, as previously reported [69,76].…”
Section: General Discussion and Conclusionsupporting
confidence: 90%
“…However, TGF-β1 secretion was much higher in M -IL-4/-IL-13 , than M -PMA and M -LPS/-IFNγ , suggesting that the M -IL-4/-IL-13 might have a potential capability to trigger fibroblast differentiation. The high production of TGF-β1 by M -IL-4/-IL-13 is in line with other reports [66,67]. In the co-culture condition with M -IL-4/-IL-13 , an increased amount of TGF-β1 was detected ( Supplementary Figure S3), indicating that myofibroblasts additively secreted TGF-β1 to maintain fibroblast differentiation in a matrix density dependent manner.…”
Section: Il-4/il-13 Triggers Fibroblast Differentiation Into Myofibsupporting
confidence: 91%
“…Additionally, human dermal fibroblasts can be “transiently” activated to go forward to myofibroblast differentiation (αSMA expression) [ 88 , 89 ]. Permanent or sequential presence of TGF-β1 and IL-10 might modify the proliferation and migration of fibroblasts and their activated form-myofibroblasts [ 90 ]. Study has shown that the removal of TGF-β1 after initial stimulation resulted in an increase of apoptosis of myofibroblasts [ 90 ].…”
Section: Estrogen Signaling On the Proliferation Processmentioning
confidence: 99%
“…Permanent or sequential presence of TGF-β1 and IL-10 might modify the proliferation and migration of fibroblasts and their activated form-myofibroblasts [ 90 ]. Study has shown that the removal of TGF-β1 after initial stimulation resulted in an increase of apoptosis of myofibroblasts [ 90 ]. TGF-β1 stimulation followed by IL-10 treatment did not result in increased cell apoptosis, but instead led to a significant increase of cell motility and a reduction of myofibroblasts [ 90 ].…”
Section: Estrogen Signaling On the Proliferation Processmentioning
confidence: 99%
“…This was consistent with differences in the Tgfβ1:Tgfβ3 expression ratio between the combination treatments, where a delay in Tgfβ1 expression was observed following the viral protein treatment. Viral ovIL-10 has been shown to share the anti-fibrotic effects of mammalian IL-10, reducing both Tgfβ1 and αSMA production [29,43,[62][63][64][65]. Pericytes are a major source of myofibroblasts [66], and the maturation of blood vessels is critical to the resolution of fibrosis in the lung and liver [67][68][69].…”
Section: Discussionmentioning
confidence: 99%